In the last trading session, 3.68 million shares of the Sana Biotechnology Inc (NASDAQ:SANA) were traded, and its beta was 1.60. Most recently the company’s share price was $2.99, and it changed around -$0.27 or -8.28% from the last close, which brings the market valuation of the company to $667.57M. SANA currently trades at a discount to its 52-week high of $12.00, offering almost -301.34% off that amount. The share price’s 52-week low was $1.52, which indicates that the current value has risen by an impressive 49.16% since then. We note from Sana Biotechnology Inc’s average daily trading volume that its 10-day average is 3.74 million shares, with the 3-month average coming to 6.85 million.
Sana Biotechnology Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.57. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended SANA as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Sana Biotechnology Inc is expected to report earnings per share of -0.26 for the current quarter.
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Instantly SANA has showed a red trend with a performance of -8.28% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.44 on recent trading dayincreased the stock’s daily price by 13.08%. The company’s shares are currently up 83.44% year-to-date, but still down -7.14% over the last five days. On the other hand, Sana Biotechnology Inc (NASDAQ:SANA) is 81.21% up in the 30-day period. We can see from the shorts that 50.28 million shares have been sold at a short interest cover period of 3.57 day(s).
The consensus price target as assigned by Wall Street analysts is $8, which translates to bulls needing to increase their stock price by 62.62% from its current value. Analyst projections state that SANA is forecast to be at a low of $8 and a high of $8.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -83.13%. Sana Biotechnology Inc earnings are expected to increase by 17.68% in 2025, but the outlook is positive 17.56% per year for the next five years.
SANA Dividends
Sana Biotechnology Inc’s next quarterly earnings report is expected to be released in March.
Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.63% of Sana Biotechnology Inc shares, and 91.49% of them are in the hands of institutional investors. The stock currently has a share float of 100.14%. Sana Biotechnology Inc stock is held by 227.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 12.5041% of the shares, which is about 27.17 million shares worth $148.35 million.
FLAGSHIP PIONEERING INC., with 11.5062% or 25.0 million shares worth $136.51 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Growth Company Fund and Smallcap World Fund were the top two Mutual Funds as of Nov 30, 2024 . The former held 9.29 shares worth $27.77 million, making up 4.16% of all outstanding shares. On the other hand, Smallcap World Fund held roughly 5.88 shares worth around $17.58 million, which represents about 2.63% of the total shares outstanding.
